FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $901 | -100.0% | 89,403 | -44.6% | 0.00% | -80.0% |
| Q3 2022 | $3,616,000 | -34.1% | 161,373 | -27.1% | 0.01% | -28.6% |
| Q2 2022 | $5,485,000 | -2.3% | 221,360 | +52.9% | 0.01% | 0.0% |
| Q1 2022 | $5,613,000 | -11.2% | 144,789 | +34.1% | 0.01% | 0.0% |
| Q4 2021 | $6,318,000 | +133.4% | 107,992 | +136.4% | 0.01% | +133.3% |
| Q3 2021 | $2,707,000 | -57.1% | 45,682 | -37.2% | 0.00% | -57.1% |
| Q2 2021 | $6,317,000 | +3278.1% | 72,787 | +3092.4% | 0.01% | – |
| Q1 2021 | $187,000 | +30.8% | 2,280 | +44.0% | 0.00% | – |
| Q4 2020 | $143,000 | +3475.0% | 1,583 | +1253.0% | 0.00% | – |
| Q2 2020 | $4,000 | – | 117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |